Skip to main content
Equibles

Carlyle Group Inc.

Position in PHAT — Phathom Pharmaceuticals, Inc.

CIK 1527166 WASHINGTON, DC
Back to PHAT Full portfolio

Position in PHAT

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$37,940,366
-$909,170 QoQ
Shares Held
3,496,808
0.0% QoQ
Ownership
4.32%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
#5
of 161 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in PHAT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Carlyle Group Inc. holds $44,066,764 across 6 Biotechnology names. PHAT ranks #1 (86.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 PHAT
Phathom Pharmaceuticals, Inc.
This page 		3,496,808 $37,940,366
2 SPRB
Spruce Biosciences, Inc.
 38,620 $2,085,480
3 ACET
Adicet Bio, Inc.
 184,295 $1,592,308
4 OKUR
OnKure Therapeutics, Inc.
 269,895 $1,230,721
5 QTTB
Q32 Bio Inc.
 60,363 $769,024
6 JSPR
Jasper Therapeutics, Inc.
 1,066,189 $448,865

All Filings in PHAT

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $37,940,366 3,496,808
2026-03-31 $38,849,536 3,496,808
2025-12-31 $58,012,044 3,496,808
2025-09-30 $41,157,430 3,496,808
2025-06-30 $33,534,388 3,496,808
2025-03-31 $21,924,986 3,496,808
2024-12-31 $28,394,080 3,496,808
2024-09-30 $63,222,288 3,496,808
2024-06-30 $36,017,122 3,496,808
2024-03-31 $37,136,100 3,496,808
2023-12-31 $31,925,857 3,496,808
2023-09-30 $36,261,898 3,496,808
2023-06-30 $50,074,290 3,496,808
2023-03-31 $20,956,656 2,935,106